|
|
|
| |
Blairs Ag Cattle Co.'s entire herd (cows/sires and
calves) are Igenity tested. |
| |
|
| |
 |
Igenity
delivers the most comprehensive genetic profile
available today - all from a single DNA sample.
This information helps beef and dairy producers make
more informed and confident decisions about breeding,
managing and marketing earlier than ever before - and
throughout an animal's lifetime. For more
information on Igenity, go to
www.igenity.com. |
|
|
|
IGENITY® Carcass
Composition
The IGENITY Profile includes information on
Quality Grade, Yield Grade, Tenderness, Fat
thickness, Marbling, Hot carcass weight,
Ribeye area. IGENITY results report
the scores (1-10) obtained from
analysis of multiple markers in genes
related to carcass composition.
This analysis associates the genotype result
with the magnitude, or size, of the trait
identified. In general, animals with low
scores for fat thickness and yield grade
will have high scores for hot carcass weight
and ribeye area.
For more detailed
information on these numbers, click here. |
|
|
RED TOWAW
INTEGRITY'S IGENITY #s - |
|
 |
|
Tenderness |
TBA |
|
Yield Grade |
3 |
|
Ribeye |
7 |
|
Carcass Weight |
8 |
|
Percent Choice |
7 |
|
Marbling Score |
8 |
|
|
|
 |
Merial is a world-leading, innovation-driven
animal health company, providing a comprehensive range
of products to enhance the health, well-being and
performance of a wide range of animals. Merial employs
approximately 6,000 people and operates in more than 150
countries worldwide. Its 2004 sales were in excess of
$1.8 billion. Merial Limited is a joint venture between
Merck & Co., Inc. and sanofi-aventis. For more
information, please see
www.merial.com. |
|
|
|
IGENITY® Profile Expands to Include
Analyses for Fertility, Docility and More
Comprehensive profile includes more
traits vital to cow/calf producers’ success
Merial
announces the expansion of the IGENITY®
profile with the addition of analyses for
heifer pregnancy rate, stayability
(longevity), calving ease and docility.
“This expansion of the comprehensive IGENITY
profile is something cow/calf producers have
been waiting for,” says Dr. Stewart Bauck,
Executive Director of Strategic Marketing,
IGENITY. “Traits like fertility, stayability
and docility are important to their success,
and until now, they were difficult to
measure.”
With these new analyses and those already
part of the IGENITY profile, Dr. Bauck says
producers can be more confident than ever
before in their seedstock selection
decisions.
“Since the IGENITY profile is comprehensive,
producers can use it alongside traditional
selection tools to better evaluate heifers
and bulls at a young age for a long list of
economically important traits,” he explains.
“The power of DNA can help producers have
more confidence that they are introducing
cattle that will help improve the overall
genetic composition of their herd and help
avoid mistakes.”
In addition to heifer pregnancy rate,
stayability, calving ease and docility, the
IGENITY profile includes multiple-marker
analyses for tenderness, marbling, quality
grade, fat thickness, ribeye area, hot
carcass weight, yield grade and coat color.
Current customers of IGENITY will have the
first preview of this profile expansion.
“All customers who have submitted samples
since October 1 will receive, free of
charge, updated reports for each animal
profiled during that period,” Dr. Bauck
says. “Those updates will be distributed
automatically, and all new samples received
will be analyzed for all traits in the newly
updated comprehensive IGENITY profile.”
Dr. Bauck says the addition of heifer
pregnancy rate, stayability, calving ease
and docility to the IGENITY profile makes
this technology more useful and
cost-effective than ever before.
“With the new analyses available from the
IGENITY profile, cow/calf producers can
learn inside information to help manage
these variables and increase their bottom
lines,” he says. “The comprehensive IGENITY
profile now includes analyses that can help
the entire beef production chain be more
efficient and produce a more consistent end
product for consumers.” |
|
|
|
|
|
